222 related articles for article (PubMed ID: 29751081)
1. LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer.
Wu HX; Cheng X; Jing XQ; Ji XP; Chen XZ; Zhang YQ; He YG; Liu K; Ye F; Sun HX; Gao HJ; Song ZJ; Wu H; Zhang XJ; Zhang T; Zhao R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2769-2784. PubMed ID: 29751081
[TBL] [Abstract][Full Text] [Related]
2. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
5. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer.
Wang J; Wang Y; Wang S; Cai J; Shi J; Sui X; Cao Y; Huang W; Chen X; Cai Z; Li H; Bardeesi AS; Zhang B; Liu M; Song W; Wang M; Xiang AP
Oncotarget; 2015 Dec; 6(40):42825-37. PubMed ID: 26517517
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
Wang LF; Liu YS; Yang B; Li P; Cheng XS; Xiao CX; Liu JJ; Li S; Ren JL; Guleng B
Oncogene; 2018 Feb; 37(5):601-615. PubMed ID: 28991232
[TBL] [Abstract][Full Text] [Related]
8. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer.
Yorozu A; Yamamoto E; Niinuma T; Tsuyada A; Maruyama R; Kitajima H; Numata Y; Kai M; Sudo G; Kubo T; Nishidate T; Okita K; Takemasa I; Nakase H; Sugai T; Takano K; Suzuki H
Cancer Sci; 2020 May; 111(5):1631-1644. PubMed ID: 32086986
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
[TBL] [Abstract][Full Text] [Related]
12. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
[TBL] [Abstract][Full Text] [Related]
14. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
15. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
16. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
[TBL] [Abstract][Full Text] [Related]
17. Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein.
Lei C; Lv S; Wang H; Liu C; Zhai Q; Wang S; Cai G; Lu D; Sun Z; Wei Q
DNA Cell Biol; 2018 Aug; 37(8):659-669. PubMed ID: 29902078
[TBL] [Abstract][Full Text] [Related]
18. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
[TBL] [Abstract][Full Text] [Related]
20. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
